No products in the cart.
Due to a schedule conflict, the call is moved to Thursday August 26th at 5:00PM [...]
Conference Call to be held on Monday, August 23rd, 2021 at 5:00 PM EST NEW [...]
Increase of 65% YoY, and 29% from Q1-2021 due to strong Pathology Growth and HemeScreen [...]
NEW HAVEN, CT, (Jun 15th, 2021) – Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that as part [...]
Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes [...]
Conference Call to be held on Thursday, May 20th, 2021 at 5:00 PM EST NEW [...]
Physician Office Laboratory (POL) Customers will be able to immediately integrate this important test into [...]
Nirmidas’ test is available to POC healthcare providers with an Amazon business account NEW HAVEN, [...]
Precipio reaffirms forecast that product revenues will reach approximately 50% of pathology revenue by the [...]
NEW HAVEN, CT, (April 5th, 2021) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces a new [...]
Username or email address *
Remember me Log in
Lost your password?